KEAP1 and hepatocellular carcinoma: A chemical inhibitor of KEAP1 that blocks its interaction with phosphorylated p62 facilitates Nrf2 degradation to suppress tumor-cell proliferation and increase sorafenib sensitivity in HCC cell lines [71].